EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS141-08478 
Organism
Homo sapiens 
Tissue/cell
NB4 
Coordinate
chr17:76754660-76756400 
Target genes
Number: 6             
NameEnsembl ID
TF binding sites/motifs
Number: 3             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
IRF1MA0050.2chr17:76754811-76754832AAAGAAAAAAAGAAAGGAAAG-6.28
IRF1MA0050.2chr17:76754799-76754820AAAACAAAAAAGAAAGAAAAA-6.46
Myod1MA0499.1chr17:76755530-76755543AGCAACAGCTGCA-6.64
Number of super-enhancer constituents: 30             
IDCoordinateTissue/cell
SE_09291chr17:76753984-76756575CD14
SE_10232chr17:76752298-76756594CD19_Primary
SE_10917chr17:76751138-76759481CD20
SE_11911chr17:76752262-76756533CD3
SE_13166chr17:76754727-76756430CD34_Primary_RO01480
SE_13786chr17:76754583-76756366CD34_Primary_RO01536
SE_14447chr17:76753823-76756459CD4_Memory_Primary_7pool
SE_15851chr17:76753860-76756483CD4_Naive_Primary_7pool
SE_16882chr17:76753872-76756526CD4p_CD225int_CD127p_Tmem
SE_17330chr17:76737257-76756438CD4p_CD25-_CD45RAp_Naive
SE_17789chr17:76752161-76756541CD4p_CD25-_CD45ROp_Memory
SE_18275chr17:76708858-76756450CD4p_CD25-_Il17-_PMAstim_Th
SE_19133chr17:76751388-76756545CD4p_CD25-_Il17p_PMAstim_Th17
SE_20047chr17:76738945-76758607CD56
SE_20904chr17:76753941-76756405CD8_Memory_7pool
SE_21491chr17:76753776-76756440CD8_Naive_7pool
SE_22344chr17:76730576-76756522CD8_primiary
SE_26201chr17:76754539-76756453Duodenum_Smooth_Muscle
SE_26756chr17:76754730-76755671Esophagus
SE_30589chr17:76754957-76756339Fetal_Muscle
SE_32461chr17:76754745-76756452GM12878
SE_43543chr17:76754397-76756439MM1S
SE_50271chr17:76754657-76756419Sigmoid_Colon
SE_52658chr17:76754612-76756440Small_Intestine
SE_53636chr17:76754642-76756414Spleen
SE_60415chr17:76679151-76756346DHL6
SE_60995chr17:76690240-76779668HBL1
SE_61668chr17:76693174-76787177Toledo
SE_62236chr17:76690401-76817069Tonsil
SE_67253chr17:76754397-76756439MM1S
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr177675477676755666
chr177675533076755871
Enhancer Sequence
CTGTAATCCC AGCTACTCGC TAGGCTGAGG CAAGAGAATT GCTTGAACCC AGGAGGCGGA 60
GGAGGTTGCA GTGGGCCGAG ATTGCACCAT TGTATTCCAG CCTGGGCAAC AAGAGTGAAA 120
CTCGAAACTC CATCTCAAAA AAACAAAAAA GAAAGAAAAA AAGAAAGGAA AGTGCTAAGT 180
CCTTGGTGGT CCTTGGTTCC TCAGCTGTAG GCAAACCCAA TTCATGCATA GACATCATCT 240
GGGCCCATCA TGTCACCCCA CGAGACTTGA GGTCAGGGGC ACCAGCACTT TCATGCTGAT 300
ATTCCTGCTA TTTGCTGTGC GATGTGTACT AATCTGCCTC ATTCTGATCC AGTAGGTCTC 360
GTTATCTACT TTCGGCATCC ACGGAGTTAT GGCATGTGCT TGTGGCCCTA GCTACTCAGG 420
AAGCTGAGGT GGGAGGATTG CTTAAGCATA GGAGATCGAG GTTGCAGTGG GCTATGACAA 480
CACCACTGCA CTCCAGCCTG GTCAACAGAG TGAGATCCTG TCTCAAAACA GAAAGAAAAT 540
TTCCATAATA ATAATTTTCT CAATGTTTGC CAAAGTGCTA AAGTAAGAAG GGCACAATTG 600
TAGCCAATCG AAGCCCACTG CCTGAGGTGG CTTCATTTTC AGACTATATG GCAACTGCCC 660
CGAGGAAGGA CTAAAAGGTA CTCTCCAAAG ACACTCTGGG TAAGTGGACG CAGCCTCAGT 720
TCTTCGTAGG TCTCATGCGC CTAGCAGTCT ACATCCCAGC GCCAAGCCTC TCTTTCATCC 780
AACGGGGTAG GCAAAGGGGT CTTTTTAGGT TGCTTCCTCA CTGTTGTACA GATCAGGGCT 840
CTAAAACTGG CACCTGGCCA CTGGCTGCCT AGCAACAGCT GCAACATAAA GAGACGGTAT 900
CTCTTAAAAG GAACAAAACA GAAAACCACA CAAAGACACA TGGGGAAGCT AAAGTGGGTA 960
GGTAGCTATA TACTTGGTAG CTATAATAAA GGAGTAAAAA CAAAAATCCA AGGTTGGTTA 1020
TTCTTGCTTC TTTCATCTGT TGAGCCTCTT CTTAAAAACC TCTGTAAGTT CAAAACCCTC 1080
CAAGCGGAAT ACTGAATGGC TTAAAGCAAA ACCACATAAA TTAGATAGTT ACAGCTGAGG 1140
AAATGCATTC AACACTCAGC CATCCCTTCC TACAATCATG GACGCACAAA TTCTTGTGAA 1200
ATCATTTTAT ACACTCAACA CGGGAAATGA AGGGAAGCAT CTCTGGCCAG GCCAACTCAA 1260
GCCAGAGCCT GCCTGTGTGA TGTGACCTTG GAGAGAACAG TTAGAGGTTC TGAAGCGTGA 1320
GTTTCCACAC CTGGGGTCCC CAAATTTAGG GGCATTAGAA GTATATTTGT GTGCATGTGT 1380
GTACAAGCAT GTGCATGTAT GTACGTATTT ATTCATTCAC TCATTCCTGG ATCTGCCCTG 1440
GTACGTTTGG TATGGCTAGA GTAAGGAACC AGAATAAATG GCTTTTTTGA AAGATTCCTC 1500
CAGGGATTCT GCGGGTTAGT CAAGTATGGG AACCACCATT CTAACCCAAA TTTACTAGAT 1560
TACGAACTTT AAAAGGGAAG GCTAAACAAA CCACTTCTGC ATGTTCATCT GCCTAGGACA 1620
TCTGCTACCA CAATTGCAAA AGGTGCCCAT GTGGAACGGA AAATACATGG TTGAATTTTA 1680
CAAATTTAGA CATATAAAGC TAAAAACTCA AGAAACACTG AATTCCCTCT TTTGACTACT 1740